Santhera and ReveraGen Start Rolling NDA Submission to the FDA for Vamorolone for the Treatment of Duchenne Muscular Dystrophy
Pratteln, Switzerland, March 29, 2022 – Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc (US: private)…
Pratteln, Switzerland, March 29, 2022 – Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc (US: private)…
REGULATED INFORMATION Strategic focus revised and fully focused on achieving topline results of the ALLOB…
Sanofi and IGM Biosciences Announce Collaboration Agreement for Oncology, Immunology and Inflammation Targets …
Toronto, Ontario–(Newsfile Corp. – March 29, 2022) – ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF)…
TOKYO, Mar 29, 2022 – (JCN Newswire) – Hitachi, Ltd. (TSE: 6501) today announced that…
HONG KONG, Mar 29, 2022 – (ACN Newswire) – Green Radar is pleased to announce…
HONG KONG, Mar 29, 2022 – (ACN Newswire) – Tai Hing Group Holdings Limited (“Tai…
HONG KONG, Mar 29, 2022 – (ACN Newswire) – Industrial Securities initiated coverage on Yeahka…
HONG KONG, Mar 29, 2022 – (ACN Newswire) – Tai Hing Group Holdings Limited (“Tai…
Key Appointment as Company Launches Instrument-Free Molecular Product OXFORD & CAMBRIDGE, England & BOSTON, Mass.–(BUSINESS…
LONDON–(BUSINESS WIRE)–London Bullion Market Association (LBMA) and the World Gold Council (WGC) are collaborating to…
PARIS & NEW YORK & TORONTO & CASABLANCA, Morocco–(BUSINESS WIRE)–Linedata (Euronext Paris: LIN) (Paris:LIN), a…
Cumulative funding reaches over US $200 million in total TOKYO, 2022, March 29 – Synspective…
– MOU to supply large-scale CO2 compression equipment for world’s largest carbon capture and storage…
Sanofi continues on path to industry leadership in Immunology with Dupixent® (dupilumab) as key driver…
VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) — Novelion Therapeutics Inc. (“Novelion” or the…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc., (“CANbridge,” stock code 1228.HK) a leading China-based global…
Company raises $32 million in private placement Trading under “PEGY” on the Nasdaq Capital Market…
PASADENA, Calif.–(BUSINESS WIRE)–$HLGN #ArtificialIntelligence–Heliogen, Inc. (“Heliogen” or the “Company”) (NYSE: HLGN), a leading provider of…